Dementia Clinical Trials

Find Dementia Clinical Trials Near You

Validation of a Remediation Method for Memory Impairments Through Motor Encoding in Patients With Alzheimer's Disease

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In France, over 1.5 million people suffer from mild cognitive impairment, often a precursor to Alzheimer's disease (AD), whose global prevalence could reach 153 million by 2050. With no curative treatment available, maintaining patients' autonomy at home is essential to mitigate the negative effects of institutionalization and reduce economic costs. Non-pharmacological approaches, such as cognitive training, have shown potential in stabilizing cognitive functions. Research suggests that motor networks and procedural memory remain relatively preserved in early AD, and bodily engagement during encoding enhances memory. For patients with motor impairments, motor imagery (MI) activates these networks without actual movement. Additionally, dynamic visual cues, like videos, reduce cognitive load compared to static images. This project aims to combine real action, MI, and dynamic visual supports to optimize memory. By validating 120 videos of daily activities, it will assess the impact of action on recall, evaluate MI's effectiveness for patients with mobility limitations, and confirm the superiority of videos over static images. The results could support the development of digital tools, such as serious games, to enhance patients' autonomy and address aging-related challenges.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Healthy Volunteers: t
View:

⁃ Patient group: Diagnosis of Alzheimer's disease made by one of the consulting physicians-a neurologist and/or geriatrician (Dubois et al., 2014)-at the early stage, presenting with mild memory impairment of which the patient has been informed

⁃ \- MMSE score of 21 or higher

⁃ Control group: individuals without a diagnosis of Alzheimer's disease, but meeting the other criteria listed below

• Enrollment in a social security program

• Age 60 or older

• French as a native language

• Consent to participate

Locations
Other Locations
France
Chu Grenoble
NOT_YET_RECRUITING
Grenoble
Chu de Saint Etienne
RECRUITING
Saint-etienne
HLC, Hôpital des Charpennes
NOT_YET_RECRUITING
Villeurbanne
Contact Information
Primary
Céline BORD, MD
celine.borg@chu-st-etienne.fr
(0)4 77 82 88 82
Backup
Céline LECLERCQ TRAUTVETTER, CDP
Celine.LECLERCQTRAUTVETTER@chu-stetienne.fr
(0)4 77 82 94 27
Time Frame
Start Date: 2026-07-15
Estimated Completion Date: 2028-06
Participants
Target number of participants: 80
Treatments
Experimental: Control condition
Control condition
Experimental: Motor imagery intervention
Motor imagery intervention
Experimental: Real action
Real action
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Saint Etienne

This content was sourced from clinicaltrials.gov